BIOLASE Inc. (BIOL) |
|
0.305 -0.006 (-1.99%)
|
09-20 20:41 |
|
Open: |
0.3112 |
Pre. Close: |
0.3112 |
|
High:
|
0.3199 |
Low:
|
0.305 |
|
Volume:
|
1,275,732 |
Market Cap:
|
28M |
|
|
|
|
BIOLASE, Inc. is a medical device company, which engages in developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. The company is headquartered in Irvine, California and currently employs 190 full-time employees. The firm markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. The company offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The company also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.32 - 0.322 |
0.322 - 0.324 |
|
Low:
|
0.306 - 0.308 |
0.308 - 0.31 |
|
Close:
|
0.307 - 0.31 |
0.31 - 0.313 |
|
Technical analysis |
as of: 2020-09-18 4:28:39 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 0.42 One year: 0.50 |
| Support: |
Support1: 0.25 Support2: 0.21 |
| Resistance: |
Resistance1: 0.36 Resistance2: 0.43 |
| Pivot: |
0.30 |
| Moving Average: |
MA(5): 0.31  MA(20): 0.31
MA(100): 0.42 MA(250): 0.53 |
| MACD: |
MACD(12,26): -0.02 Signal(9): -0.03 |
| Stochastic oscillator: |
%K(14,3): 61.67 %D(3): 60.74 |
| RSI: |
RSI(14): 39.32 |
| 52-week: |
High: 1.07 Low: 0.21 Change(%): -68.6 |
| Average Vol(K): |
3-Month: 753710 10-Days: 285998 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.BIOL has closed below upper band by 39.4%. Bollinger Bands are 58.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to BIOL's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Fri, 18 Sep 2020
BIOLASE, Inc. (NASDAQ:BIOL) Stock Fell -43.69% Year-To-Date, What Analysts Expect Next? - Marketing Sentinel
Thu, 17 Sep 2020
BIOLASE Inc. (NASDAQ:BIOL) is Gaining Momentum on Earnings Catalyst - The Oracle Dispatch
Thu, 17 Sep 2020
Analysts Offer Important Insight on BIOLASE, Inc. (BIOL) - Stocks Register
Thu, 17 Sep 2020
Here's Our Rant About BIOLASE, Inc. (BIOL) - The News Heater
Fri, 11 Sep 2020
BIOLASE To Present At HC Wainwright's 22nd Annual Global Investor Conference - PRNewswire
Wed, 09 Sep 2020
BIOLASE Inc. (BIOL) is on the roll with an average volume of 8.38M in the recent 3 months - The InvestChronicle
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
92 |
| Shares Float (M) |
84 |
|
% Held by Insiders
|
27.02 |
|
% Held by Institutions
|
37.78 |
|
Shares Short (K)
|
513 |
|
Shares Short P. Month (K)
|
616 |
Stock Financials |
|
EPS
|
-0.665 |
|
EPS Est This Year
|
-0.160 |
|
EPS Est Next Year
|
-0.100 |
|
Book Value (p.s.)
|
0.030 |
|
Profit Margin
|
-74.43 |
|
Operating Margin
|
-64.97 |
|
Return on Assets (ttm)
|
-35.9 |
|
Return on Equity (ttm)
|
-774.8 |
|
Qtrly Rev. Growth
|
-66.0 |
|
Gross Profit (p.s.)
|
0.155 |
|
Sales Per Share
|
0.288 |
|
EBITDA (p.s.)
|
-0.177 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-15 |
|
Levered Free Cash Flow (M)
|
-7 |
Stock Valuations |
|
PE Ratio
|
-0.46 |
|
PEG Ratio
|
|
|
Price to Book value
|
10.17 |
|
Price to Sales
|
1.06 |
|
Price to Cash Flow
|
-1.82 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
2005-06-23 |
|
7 Binary Options
|
|
Your Ad Here
|
|
